Accéder au contenu
Merck
  • Disrupting D1-NMDA or D2-NMDA receptor heteromerization prevents cocaine's rewarding effects but preserves natural reward processing.

Disrupting D1-NMDA or D2-NMDA receptor heteromerization prevents cocaine's rewarding effects but preserves natural reward processing.

Science advances (2021-10-21)
Andry Andrianarivelo, Estefani Saint-Jour, Paula Pousinha, Sebastian P Fernandez, Anna Petitbon, Veronique De Smedt-Peyrusse, Nicolas Heck, Vanesa Ortiz, Marie-Charlotte Allichon, Vincent Kappès, Sandrine Betuing, Roman Walle, Ying Zhu, Charlène Joséphine, Alexis-Pierre Bemelmans, Gustavo Turecki, Naguib Mechawar, Jonathan A Javitch, Jocelyne Caboche, Pierre Trifilieff, Jacques Barik, Peter Vanhoutte
RÉSUMÉ

[Figure: see text].

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-D1 Dopamine Receptor antibody,Rat monoclonal, clone 1-1-F11 s.E6, purified from hybridoma cell culture
Sigma-Aldrich
Anticorps anti-NR1, CT, Upstate®, from mouse
Sigma-Aldrich
Anticorps anti-récepteur dopaminergique D2, from rabbit, purified by affinity chromatography
Sigma-Aldrich
Anti-NMDAR2B Antibody, NT, ascites fluid, clone 1A8.9B3, Chemicon®